- Home
- CALC vs EDRY Comparison
CALC vs EDRY Comparison
Compare CALC & EDRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CALC
- EDRY
- Stock Information
- Founded
- CALC 2011
- EDRY 2018
- Country
- CALC United States
- EDRY Greece
- Employees
- CALC N/A
- EDRY N/A
- Industry
- CALC Biotechnology: Pharmaceutical Preparations
- EDRY Marine Transportation
- Sector
- CALC Health Care
- EDRY Consumer Discretionary
- Exchange
- CALC Nasdaq
- EDRY Nasdaq
- Market Cap
- CALC 22.9M
- EDRY 27.3M
- IPO Year
- CALC N/A
- EDRY N/A
- Fundamental
- Price
- CALC $2.03
- EDRY $10.60
- Analyst Decision
- CALC Strong Buy
- EDRY
- Analyst Count
- CALC 2
- EDRY 0
- Target Price
- CALC $14.50
- EDRY N/A
- AVG Volume (30 Days)
- CALC 66.9K
- EDRY 7.0K
- Earning Date
- CALC 08-11-2025
- EDRY 08-07-2025
- Dividend Yield
- CALC N/A
- EDRY N/A
- EPS Growth
- CALC N/A
- EDRY N/A
- EPS
- CALC N/A
- EDRY N/A
- Revenue
- CALC N/A
- EDRY $55,867,583.00
- Revenue This Year
- CALC N/A
- EDRY N/A
- Revenue Next Year
- CALC N/A
- EDRY $28.27
- P/E Ratio
- CALC N/A
- EDRY N/A
- Revenue Growth
- CALC N/A
- EDRY 10.25
- 52 Week Low
- CALC $1.42
- EDRY $7.60
- 52 Week High
- CALC $5.97
- EDRY $24.72
- Technical
- Relative Strength Index (RSI)
- CALC 69.39
- EDRY 69.47
- Support Level
- CALC $1.59
- EDRY $9.78
- Resistance Level
- CALC $2.59
- EDRY $10.44
- Average True Range (ATR)
- CALC 0.18
- EDRY 0.71
- MACD
- CALC 0.08
- EDRY 0.10
- Stochastic Oscillator
- CALC 66.67
- EDRY 56.90
About CALC CalciMedica Inc.
CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapeutics that treat serious illnesses driven by inflammatory and immunologic processes and direct cellular damage. Its product candidates act upon calcium release-activated calcium (CRAC) channels and would constitute a new class of drugs. Its product candidate is Auxora, a potent and selective intravenous formulated small molecule CRAC channel inhibitor containing the active compound zegocractin (formerly referred to as CM4620) that, in animal models, reduced acute epithelial and/or endothelial cell injury and inflammation in organs, such as the pancreas, lungs and kidneys.
About EDRY EuroDry Ltd.
EuroDry Ltd is a holding company. It is a provider of ocean-going transportation. The company owns and operates dry bulk carriers that transport bulk such as iron ore, coal, and grains, and minor bulks such as bauxite, phosphate, and fertilizers. It operates under one operating and one reportable segment, that of operating dry bulk vessels.